Randomized pilot vs usual dose of lenalidomide dose reduction in patients with relapsed multiple myeloma who have reached maximum response. [No Ensayo piloto aleatorizado de dosis habitual de lenalidomida vs reducción de dosis en pacientes con mieloma múltiple en recaída que han alcanzado máxima respuesta]

Trial Profile

Randomized pilot vs usual dose of lenalidomide dose reduction in patients with relapsed multiple myeloma who have reached maximum response. [No Ensayo piloto aleatorizado de dosis habitual de lenalidomida vs reducción de dosis en pacientes con mieloma múltiple en recaída que han alcanzado máxima respuesta]

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2017

At a glance

  • Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 Mar 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 09 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top